Selected research
Market Structure
Global Medical Device Viral Inactivation Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Device Viral Inactivation Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Device Viral Inactivation Testing include Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, Texcell, Intertek Group, LabCorp, Syensqo and SGS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Medical Device Viral Inactivation Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Device Viral Inactivation Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Device Viral Inactivation Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Device Viral Inactivation Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Device Viral Inactivation Testing Segment by Company
Charles River
Perfectus Biomed (NAMSA)
Eurofins Scientific
Nelson Labs
Texcell
Intertek Group
LabCorp
Syensqo
SGS
Pacific BioLabs
Creative Biogene
ProPharma Group
Cormica Lab (Wickham Micro)
CTI
WuXi AppTec
Medical Device Viral Inactivation Testing Segment by Type
DNA-based
RNA-based
Medical Device Viral Inactivation Testing Segment by Application
Active Implant Medical Devices
Active Medical Equipment
In Vitro Diagnostic Equipment
Ophthalmic Medical Equipment
Vascular Medical Equipment
Other
Medical Device Viral Inactivation Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Viral Inactivation Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Viral Inactivation Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Viral Inactivation Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Device Viral Inactivation Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Device Viral Inactivation Testing industry.
Chapter 3: Detailed analysis of Medical Device Viral Inactivation Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Device Viral Inactivation Testingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of DNA-based
Table 3. Key Players of RNA-based
Table 4. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Active Implant Medical Devices
Table 6. Key Players of Active Medical Equipment
Table 7. Key Players of In Vitro Diagnostic Equipment
Table 8. Key Players of Ophthalmic Medical Equipment
Table 9. Key Players of Vascular Medical Equipment
Table 10. Key Players of Other
Table 11. Global Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 12. Global Medical Device Viral Inactivation Testing Market Size by Region (2021-2026) & (US$ Million)
Table 13. Global Medical Device Viral Inactivation Testing Market Share by Region (2021-2026)
Table 14. Global Medical Device Viral Inactivation Testing Market Size by Region (2027-2032) & (US$ Million)
Table 15. Global Medical Device Viral Inactivation Testing Market Share by Region (2027-2032)
Table 16. Medical Device Viral Inactivation Testing Industry Trends
Table 17. Medical Device Viral Inactivation Testing Industry Drivers
Table 18. Medical Device Viral Inactivation Testing Industry Opportunities and Challenges
Table 19. Medical Device Viral Inactivation Testing Industry Restraints
Table 20. Global Medical Device Viral Inactivation Testing Revenue by Company (US$ Million) & (2021-2026)
Table 21. Global Medical Device Viral Inactivation Testing Revenue Market Share by Company (2021-2026)
Table 22. Global Medical Device Viral Inactivation Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 23. Global Medical Device Viral Inactivation Testing Key Company Head Office and Area Served
Table 24. Global Medical Device Viral Inactivation Testing Company, Product Type & Application
Table 25. Global Medical Device Viral Inactivation Testing Company Establishment Date
Table 26. Global Company Market Concentration Ratio (CR5 and HHI)
Table 27. Global Medical Device Viral Inactivation Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 28. Global Medical Device Viral Inactivation Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 30. Global Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (US$ Million)
Table 31. Global Medical Device Viral Inactivation Testing Revenue Market Share by Type (2021-2026)
Table 32. Global Medical Device Viral Inactivation Testing Revenue Market Share by Type (2027-2032)
Table 33. Global Medical Device Viral Inactivation Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 35. Global Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (US$ Million)
Table 36. Global Medical Device Viral Inactivation Testing Revenue Market Share by Application (2021-2026)
Table 37. Global Medical Device Viral Inactivation Testing Revenue Market Share by Application (2027-2032)
Table 38. Charles River Company Information
Table 39. Charles River Business Overview
Table 40. Charles River Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 41. Charles River Medical Device Viral Inactivation Testing Product Portfolio
Table 42. Charles River Recent Development
Table 43. Perfectus Biomed (NAMSA) Company Information
Table 44. Perfectus Biomed (NAMSA) Business Overview
Table 45. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 46. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product Portfolio
Table 47. Perfectus Biomed (NAMSA) Recent Development
Table 48. Eurofins Scientific Company Information
Table 49. Eurofins Scientific Business Overview
Table 50. Eurofins Scientific Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 51. Eurofins Scientific Medical Device Viral Inactivation Testing Product Portfolio
Table 52. Eurofins Scientific Recent Development
Table 53. Nelson Labs Company Information
Table 54. Nelson Labs Business Overview
Table 55. Nelson Labs Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 56. Nelson Labs Medical Device Viral Inactivation Testing Product Portfolio
Table 57. Nelson Labs Recent Development
Table 58. Texcell Company Information
Table 59. Texcell Business Overview
Table 60. Texcell Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 61. Texcell Medical Device Viral Inactivation Testing Product Portfolio
Table 62. Texcell Recent Development
Table 63. Intertek Group Company Information
Table 64. Intertek Group Business Overview
Table 65. Intertek Group Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 66. Intertek Group Medical Device Viral Inactivation Testing Product Portfolio
Table 67. Intertek Group Recent Development
Table 68. LabCorp Company Information
Table 69. LabCorp Business Overview
Table 70. LabCorp Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 71. LabCorp Medical Device Viral Inactivation Testing Product Portfolio
Table 72. LabCorp Recent Development
Table 73. Syensqo Company Information
Table 74. Syensqo Business Overview
Table 75. Syensqo Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 76. Syensqo Medical Device Viral Inactivation Testing Product Portfolio
Table 77. Syensqo Recent Development
Table 78. SGS Company Information
Table 79. SGS Business Overview
Table 80. SGS Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 81. SGS Medical Device Viral Inactivation Testing Product Portfolio
Table 82. SGS Recent Development
Table 83. Pacific BioLabs Company Information
Table 84. Pacific BioLabs Business Overview
Table 85. Pacific BioLabs Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 86. Pacific BioLabs Medical Device Viral Inactivation Testing Product Portfolio
Table 87. Pacific BioLabs Recent Development
Table 88. Creative Biogene Company Information
Table 89. Creative Biogene Business Overview
Table 90. Creative Biogene Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 91. Creative Biogene Medical Device Viral Inactivation Testing Product Portfolio
Table 92. Creative Biogene Recent Development
Table 93. ProPharma Group Company Information
Table 94. ProPharma Group Business Overview
Table 95. ProPharma Group Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 96. ProPharma Group Medical Device Viral Inactivation Testing Product Portfolio
Table 97. ProPharma Group Recent Development
Table 98. Cormica Lab (Wickham Micro) Company Information
Table 99. Cormica Lab (Wickham Micro) Business Overview
Table 100. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 101. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product Portfolio
Table 102. Cormica Lab (Wickham Micro) Recent Development
Table 103. CTI Company Information
Table 104. CTI Business Overview
Table 105. CTI Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 106. CTI Medical Device Viral Inactivation Testing Product Portfolio
Table 107. CTI Recent Development
Table 108. WuXi AppTec Company Information
Table 109. WuXi AppTec Business Overview
Table 110. WuXi AppTec Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 111. WuXi AppTec Medical Device Viral Inactivation Testing Product Portfolio
Table 112. WuXi AppTec Recent Development
Table 113. North America Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 114. North America Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (US$ Million)
Table 115. North America Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 116. North America Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (US$ Million)
Table 117. North America Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 118. North America Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
Table 119. North America Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
Table 120. Europe Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 121. Europe Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (US$ Million)
Table 122. Europe Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 123. Europe Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (US$ Million)
Table 124. Europe Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 125. Europe Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
Table 126. Europe Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
Table 127. China Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 128. China Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (US$ Million)
Table 129. China Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 130. China Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (US$ Million)
Table 131. Asia Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 132. Asia Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (US$ Million)
Table 133. Asia Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 134. Asia Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (US$ Million)
Table 135. Asia Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 136. Asia Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
Table 137. Asia Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
Table 138. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 139. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Type (2027-2032) & (US$ Million)
Table 140. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 141. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Application (2027-2032) & (US$ Million)
Table 142. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 143. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
Table 144. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
Table 145. Research Programs/Design for This Report
Table 146. Authors List of This Report
Table 147. Secondary Sources
Table 148. Primary Sources
List of Figures
Figure 1. Medical Device Viral Inactivation Testing Product Image
Figure 2. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global Medical Device Viral Inactivation Testing Market Share by Type: 2025 VS 2032
Figure 4. DNA-based Image
Figure 5. RNA-based Image
Figure 6. Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 7. Global Medical Device Viral Inactivation Testing Market Share by Application: 2025 VS 2032
Figure 8. Active Implant Medical Devices Image
Figure 9. Active Medical Equipment Image
Figure 10. In Vitro Diagnostic Equipment Image
Figure 11. Ophthalmic Medical Equipment Image
Figure 12. Vascular Medical Equipment Image
Figure 13. Other Image
Figure 14. Global Medical Device Viral Inactivation Testing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 15. Global Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 16. Global Medical Device Viral Inactivation Testing Market Share by Region: 2025 VS 2032
Figure 17. Years Considered
Figure 18. Global Medical Device Viral Inactivation Testing Market Share by Players in 2025
Figure 19. Global Top 5 and 10 Medical Device Viral Inactivation Testing Players Market Share by Revenue in 2025
Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. Global Medical Device Viral Inactivation Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Medical Device Viral Inactivation Testing Revenue Market Share by Type (2021-2032)
Figure 23. Global Medical Device Viral Inactivation Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 24. Global Medical Device Viral Inactivation Testing Revenue Market Share by Application (2021-2032)
Figure 25. North America Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 26. North America Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
Figure 27. North America Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
Figure 28. North America Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 29. United States Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 30. Canada Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 31. Mexico Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 32. Europe Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 33. Europe Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
Figure 34. Europe Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
Figure 35. Europe Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 36. Germany Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 37. France Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 38. U.K. Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 39. Italy Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 40. Russia Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 41. Nordic Countries Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 42. China Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 43. China Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
Figure 44. China Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
Figure 45. Asia Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 46. Asia Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
Figure 47. Asia Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
Figure 48. Asia Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 49. Japan Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 50. South Korea Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 51. Taiwan Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 53. India Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 54. Australia Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 55. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 56. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
Figure 57. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
Figure 58. South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 59. Brazil Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 60. South Africa Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 61. Saudi Arabia Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 62. Turkey Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 63. Argentina Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 64. UAE Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 65. Egypt Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 66. Chile Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 67. Research Process
Figure 68. Key Executives Interviewed
Scope & coverage.
Types
- DNA-based
- RNA-based
Applications
- Active Implant Medical Devices
- Active Medical Equipment
- In Vitro Diagnostic Equipment
- Ophthalmic Medical Equipment
- Vascular Medical Equipment
- Other
Companies covered
- Charles River
- Perfectus Biomed (NAMSA)
- Eurofins Scientific
- Nelson Labs
- Texcell
- Intertek Group
- LabCorp
- Syensqo
- SGS
- Pacific BioLabs
- Creative Biogene
- ProPharma Group
- Cormica Lab (Wickham Micro)
- CTI
- WuXi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 DNA-based
- 1.2.3 RNA-based
- 1.3 Market Analysis by Application
- 1.3.1 Global Medical Device Viral Inactivation Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Active Implant Medical Devices
- 1.3.3 Active Medical Equipment
- 1.3.4 In Vitro Diagnostic Equipment
- 1.3.5 Ophthalmic Medical Equipment
- 1.3.6 Vascular Medical Equipment
- 1.3.7 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Medical Device Viral Inactivation Testing Growth Trends by Region
- 1.5.1 Global Medical Device Viral Inactivation Testing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Medical Device Viral Inactivation Testing Market Size by Region (2021-2026)
- 1.5.3 Medical Device Viral Inactivation Testing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Medical Device Viral Inactivation Testing Market Dynamics
- 2.1 Medical Device Viral Inactivation Testing Industry Trends
- 2.2 Medical Device Viral Inactivation Testing Industry Drivers
- 2.3 Medical Device Viral Inactivation Testing Industry Opportunities and Challenges
- 2.4 Medical Device Viral Inactivation Testing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Medical Device Viral Inactivation Testing Revenue by Company (2021-2026)
- 3.2 Global Medical Device Viral Inactivation Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Medical Device Viral Inactivation Testing Key Company Head office and Area Served
- 3.4 Global Medical Device Viral Inactivation Testing Company, Product Type & Application
- 3.5 Global Medical Device Viral Inactivation Testing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Medical Device Viral Inactivation Testing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Medical Device Viral Inactivation Testing Players Market Share by Revenue in 2025
- 3.6.3 2025 Medical Device Viral Inactivation Testing Tier 1, Tier 2, and Tier 3
4 Medical Device Viral Inactivation Testing Market by Type
- 4.1 Global Medical Device Viral Inactivation Testing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Medical Device Viral Inactivation Testing Market Size by Type (2021-2032)
- 4.3 Global Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2032)
5 Medical Device Viral Inactivation Testing Market by Application
- 5.1 Global Medical Device Viral Inactivation Testing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Medical Device Viral Inactivation Testing Market Size by Application (2021-2032)
- 5.3 Global Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Charles River
- 6.1.1 Charles River Company Information
- 6.1.2 Charles River Business Overview
- 6.1.3 Charles River Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Charles River Medical Device Viral Inactivation Testing Product Portfolio
- 6.1.5 Charles River Recent Developments
- 6.2 Perfectus Biomed (NAMSA)
- 6.2.1 Perfectus Biomed (NAMSA) Company Information
- 6.2.2 Perfectus Biomed (NAMSA) Business Overview
- 6.2.3 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product Portfolio
- 6.2.5 Perfectus Biomed (NAMSA) Recent Developments
- 6.3 Eurofins Scientific
- 6.3.1 Eurofins Scientific Company Information
- 6.3.2 Eurofins Scientific Business Overview
- 6.3.3 Eurofins Scientific Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Eurofins Scientific Medical Device Viral Inactivation Testing Product Portfolio
- 6.3.5 Eurofins Scientific Recent Developments
- 6.4 Nelson Labs
- 6.4.1 Nelson Labs Company Information
- 6.4.2 Nelson Labs Business Overview
- 6.4.3 Nelson Labs Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Nelson Labs Medical Device Viral Inactivation Testing Product Portfolio
- 6.4.5 Nelson Labs Recent Developments
- 6.5 Texcell
- 6.5.1 Texcell Company Information
- 6.5.2 Texcell Business Overview
- 6.5.3 Texcell Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Texcell Medical Device Viral Inactivation Testing Product Portfolio
- 6.5.5 Texcell Recent Developments
- 6.6 Intertek Group
- 6.6.1 Intertek Group Company Information
- 6.6.2 Intertek Group Business Overview
- 6.6.3 Intertek Group Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Intertek Group Medical Device Viral Inactivation Testing Product Portfolio
- 6.6.5 Intertek Group Recent Developments
- 6.7 LabCorp
- 6.7.1 LabCorp Company Information
- 6.7.2 LabCorp Business Overview
- 6.7.3 LabCorp Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 LabCorp Medical Device Viral Inactivation Testing Product Portfolio
- 6.7.5 LabCorp Recent Developments
- 6.8 Syensqo
- 6.8.1 Syensqo Company Information
- 6.8.2 Syensqo Business Overview
- 6.8.3 Syensqo Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Syensqo Medical Device Viral Inactivation Testing Product Portfolio
- 6.8.5 Syensqo Recent Developments
- 6.9 SGS
- 6.9.1 SGS Company Information
- 6.9.2 SGS Business Overview
- 6.9.3 SGS Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 SGS Medical Device Viral Inactivation Testing Product Portfolio
- 6.9.5 SGS Recent Developments
- 6.10 Pacific BioLabs
- 6.10.1 Pacific BioLabs Company Information
- 6.10.2 Pacific BioLabs Business Overview
- 6.10.3 Pacific BioLabs Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Pacific BioLabs Medical Device Viral Inactivation Testing Product Portfolio
- 6.10.5 Pacific BioLabs Recent Developments
- 6.11 Creative Biogene
- 6.11.1 Creative Biogene Company Information
- 6.11.2 Creative Biogene Business Overview
- 6.11.3 Creative Biogene Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Creative Biogene Medical Device Viral Inactivation Testing Product Portfolio
- 6.11.5 Creative Biogene Recent Developments
- 6.12 ProPharma Group
- 6.12.1 ProPharma Group Company Information
- 6.12.2 ProPharma Group Business Overview
- 6.12.3 ProPharma Group Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 ProPharma Group Medical Device Viral Inactivation Testing Product Portfolio
- 6.12.5 ProPharma Group Recent Developments
- 6.13 Cormica Lab (Wickham Micro)
- 6.13.1 Cormica Lab (Wickham Micro) Company Information
- 6.13.2 Cormica Lab (Wickham Micro) Business Overview
- 6.13.3 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product Portfolio
- 6.13.5 Cormica Lab (Wickham Micro) Recent Developments
- 6.14 CTI
- 6.14.1 CTI Company Information
- 6.14.2 CTI Business Overview
- 6.14.3 CTI Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 CTI Medical Device Viral Inactivation Testing Product Portfolio
- 6.14.5 CTI Recent Developments
- 6.15 WuXi AppTec
- 6.15.1 WuXi AppTec Company Information
- 6.15.2 WuXi AppTec Business Overview
- 6.15.3 WuXi AppTec Medical Device Viral Inactivation Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 WuXi AppTec Medical Device Viral Inactivation Testing Product Portfolio
- 6.15.5 WuXi AppTec Recent Developments
7 North America
- 7.1 North America Medical Device Viral Inactivation Testing Market Size (2021-2032)
- 7.2 North America Medical Device Viral Inactivation Testing Market Size by Type
- 7.2.1 North America Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
- 7.2.2 North America Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
- 7.2.3 North America Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
- 7.3 North America Medical Device Viral Inactivation Testing Market Size by Application
- 7.3.1 North America Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
- 7.3.2 North America Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
- 7.3.3 North America Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
- 7.4 North America Medical Device Viral Inactivation Testing Market Size by Country
- 7.4.1 North America Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 7.4.3 North America Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
- 7.4.4 North America Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Medical Device Viral Inactivation Testing Market Size (2021-2032)
- 8.2 Europe Medical Device Viral Inactivation Testing Market Size by Type
- 8.2.1 Europe Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
- 8.2.2 Europe Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
- 8.2.3 Europe Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
- 8.3 Europe Medical Device Viral Inactivation Testing Market Size by Application
- 8.3.1 Europe Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
- 8.3.2 Europe Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
- 8.3.3 Europe Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
- 8.4 Europe Medical Device Viral Inactivation Testing Market Size by Country
- 8.4.1 Europe Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 8.4.3 Europe Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
- 8.4.4 Europe Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Medical Device Viral Inactivation Testing Market Size (2021-2032)
- 9.2 China Medical Device Viral Inactivation Testing Market Size by Type
- 9.2.1 China Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
- 9.2.2 China Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
- 9.2.3 China Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
- 9.3 China Medical Device Viral Inactivation Testing Market Size by Application
- 9.3.1 China Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
- 9.3.2 China Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
- 9.3.3 China Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Medical Device Viral Inactivation Testing Market Size (2021-2032)
- 10.2 Asia Medical Device Viral Inactivation Testing Market Size by Type
- 10.2.1 Asia Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
- 10.2.2 Asia Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
- 10.2.3 Asia Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
- 10.3 Asia Medical Device Viral Inactivation Testing Market Size by Application
- 10.3.1 Asia Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
- 10.3.2 Asia Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
- 10.3.3 Asia Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
- 10.4 Asia Medical Device Viral Inactivation Testing Market Size by Country
- 10.4.1 Asia Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 10.4.3 Asia Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
- 10.4.4 Asia Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Type
- 11.2.1 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Application
- 11.3.1 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country
- 11.4.1 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst